08 February 2012: Increased reimbursement of Self-Expanding drug-eluting stents in Germany now for all indications

01 February 2012: STENTYS concludes clinical trial ahead of plan

08 November 2011: Outstanding interim results of STENTYS international clinical study APPOSITION III

12 October 2011: STENTYS Self-Apposing Stents in “perfect apposition to vessels” after treating patients with heart attacks

21 September 2011: STENTYS completes enrollment of APPOSITION III study

15 September 2011: Over 1000 patients have benefited from STENTYS Self-Apposing technology

31 August 2011: 2011 Half-Year results

26 July 2011: Revenues for the 1st half of 2011

20 June 2011: Prof. Gilles Montalescot joins STENTYS Scientific Advisory Board

08 June 2011: STENTYS recruits Country managers for France and Italy

18 May 2011: STENTYS joins Stent for Life Initiative

16 May 2011: Stenting in STEMI: Does Size Matter?

02 May 2011: STENTYS enrolls first 250 patients within the framework of its Apposition III international study

17 March 2011: STENTYS expands operations into four additional European countries

23 February 2011: Increased reimbursement of STENTYS drug-eluting stent in Germany

09 December 2010: STENTYS begins large-scale, “real life” study with its selfapposing stent for treatment of Heart Attacks

50 patients already enrolled

23 November 2010: STENTYS appoints Mr Michel Darnaud to its Board of Directors

22 September 2010: APPOSITION II clinical trial results

STENTYS self-apposing stent proves superior to conventional treatment of Acute Myocardial Infarction

09 September 2010: STENTYS completes enrollment in clinical study of its breakthrough stent to treat Acute Myocardial Infarction.

02 September 2010: STENTYS appoints Stanislas Piot as Chief Financial Officer

05 May 2010: STENTYS drug-eluting self-expanding stent receives CE Marking.

01 March 2010: STENTYS self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS).

06 February 2010: STENTYS drug-eluting self-expanding coronary stent shows 4% restenosis in complex lesions.

01 December 2009: First patient enrolled in randomized study of STENTYS self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI).

31 October 2009: STENTYS expands Scientific Advisory Board (SAB) on heels of reporting successful clinical trial results for world’s first self-expanding stent to treat AMI.

15 September 2009: STENTYS discloses results for world’s first clinical study to treat acute myocardial infarction (AMI) with a self-expanding stent.